Valuation: Procter & Gamble Hygiene and Health Care Limited

Capitalization 30TCr 319.51Cr 276.7Cr 253.89Cr 238.87Cr 444.9Cr 451.85Cr 3.02TCr 1.17TCr 15TCr 1.2TCr 1.17TCr 51TCr P/E ratio 2026
35.3x
P/E ratio 2027 * 32.9x
Enterprise value 30TCr 319.51Cr 276.7Cr 253.89Cr 238.87Cr 444.9Cr 451.85Cr 3.02TCr 1.17TCr 15TCr 1.2TCr 1.17TCr 51TCr EV / Sales 2026
7.06x
EV / Sales 2027 * 6.58x
Free-Float
29.06%
Yield 2026 *
2.3%
Yield 2027 * 2.44%
28/05 Procter & Gamble Hygiene and Health Care Limited Recommends Dividend for the Financial Year Ended March 31, 2026, Payable on or Before September 18, 2026 CI
28/05 Procter & Gamble Hygiene and Health Care Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
28/05 Procter Gamble hygiene posts March-quarter profit 1.53 billion rupees RE
28/05 Procter & Gamble Hygiene and Health Care Limited Announces CFO Changes CI
28/05 Procter & Gamble Hygiene and Health Care Limited Announces Management Changes CI
18/03 Procter & Gamble Names Robin Thadathil as New Chief Human Resources Officer of P&G India, Effective 1 April CI
17/03 Procter & Gamble Hygiene and Health Care Limited Announces Resignation of Srinivas Maruthi Patnam as Head of Human Resources, Effective March 31, 2026 CI
30/01 Procter & Gamble Hygiene and Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
30/01 Procter & Gamble Hygiene and Health Care Dec-quarter profit 3.01 billion rupees RE
30/01 Procter & Gamble Hygiene and Health Care Limited Declares One-Time Special Dividend, Payable on or Before February 27, 2026 CI
30/01 Procter & Gamble Hygiene and Health Care Limited Declares Interim Dividend for the Financial Year 2025-2026, Payable on or Before February 27, 2026 CI
08/12 Procter & Gamble Hygiene and Health Care Limited Announces Executive Changes CI
06/11 Procter & Gamble Hygiene and Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
1 day-0.50%
1 week-2.93%
Current month-2.93%
1 month-5.81%
3 months-13.76%
6 months-25.46%
Current year-27.51%
1 week 9,250
Extreme 9250
9,749.95
1 month 9,250
Extreme 9250
10,399.95
Current year 8,995
Extreme 8995
13,501.05
1 year 8,995
Extreme 8995
14,536.6
3 years 8,995
Extreme 8995
19,086.2
5 years 8,995
Extreme 8995
19,086.2
10 years 6,025
Extreme 6025
19,086.2
Manager TitleAgeSince
Chief Executive Officer - 01/05/2024
Director of Finance/CFO - 01/07/2025
Chief Tech/Sci/R&D Officer - 01/09/2025
Director TitleAgeSince
Chairman 74 24/09/2020
Director/Board Member 81 01/09/2022
Director/Board Member 70 19/03/2024
Change 5d. change 1-year change 3-years change Capi.($)
-0.50%-2.93%-30.60%-31.85% 319.51Cr
+4.09%+2.08%-10.66%+1.42% 34TCr
+2.71%-0.40%-19.80%-7.95% 12TCr
+4.09%-1.72%-1.84%+17.22% 7.09TCr
+2.02%-1.49%-11.23%-21.17% 5.23TCr
+4.92%+2.49%-18.50%-29.64% 3.4TCr
+0.71%-6.14%+21.95%-54.66% 3.02TCr
+1.10%-1.08%-6.38%-13.18% 1.85TCr
+3.61%+1.19%-41.54%-41.30% 1.77TCr
+1.27%-3.17%-11.31%+16.92% 1.67TCr
Average +2.40%-1.68%-12.99%-16.42% 7.06TCr
Weighted average by Cap. +3.42%-2.28%-11.13%-5.41%

Financials

2026 2027 *
Net sales 4.38TCr 46Cr 40Cr 37Cr 34Cr 64Cr 65Cr 434.37Cr 169.05Cr 2.12TCr 172.68Cr 168.92Cr 7.37TCr 4.63TCr 49Cr 42Cr 39Cr 36Cr 68Cr 69Cr 458.78Cr 178.55Cr 2.24TCr 182.39Cr 178.42Cr 7.78TCr
Net income 890.9Cr 9.35Cr 8.1Cr 7.43Cr 6.99Cr 13Cr 13Cr 88Cr 34Cr 430.85Cr 35Cr 34Cr 1.5TCr 927.3Cr 9.73Cr 8.43Cr 7.73Cr 7.27Cr 14Cr 14Cr 92Cr 36Cr 448.45Cr 37Cr 36Cr 1.56TCr
Net Debt - -
Logo Procter & Gamble Hygiene and Health Care Limited
Procter & Gamble Hygiene and Health Care Limited is an India-based fast-moving consumer goods (FMCG) company. The Company is engaged in manufacturing and selling branded packaged FMCG in the feminine care and healthcare businesses. The Company has two segments: Health care products and Hygiene products. The health care products segment comprises ointment and creams, cough drops and tablets. The Hygiene products segment comprises feminine hygiene products and other skin care hygiene products. Its brands include Pampers, Ariel, Tide, Whisper, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Vicks, Olay, and Old Spice. Its healthcare portfolio includes Vicks VapoRub, Vicks Cough Drops, Vicks Action 500 Advanced, Zzzquil, Vicks Inhaler, Vicks Xtra Strong Rub, Vicks Baby Rub, Vicks VapoRub Steam Pods, Vicks Headache Roll-on and Vicks Cough Syrup. Its Feminine hygiene portfolio includes Whisper Ultra, Whisper Choice, Whisper Ultra Skin Love, among others.
Employees
421
Date Price Change Volume
05/26/05 9,379.80 -0.50% 261
04/26/04 9,427.40 +1.43% 328
03/26/03 9,294.50 -0.99% 630
02/26/02 9,387.75 -0.67% 670
01/26/01 9,451.50 -2.19% 807

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 500459 Stock